Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.7 - $1.4 $76,214 - $152,429
-108,878 Reduced 99.03%
1,065 $1,000
Q1 2022

May 05, 2022

BUY
$0.63 - $1.59 $54 - $138
87 Added 0.08%
109,943 $142,000
Q4 2021

Feb 02, 2022

SELL
$1.27 - $2.42 $261 - $498
-206 Reduced 0.19%
109,856 $140,000
Q3 2021

Nov 02, 2021

BUY
$2.15 - $3.82 $808 - $1,436
376 Added 0.34%
110,062 $240,000
Q2 2021

Aug 02, 2021

BUY
$2.89 - $4.45 $3,427 - $5,277
1,186 Added 1.09%
109,686 $411,000
Q4 2020

Feb 08, 2021

BUY
$3.38 - $5.14 $10,478 - $15,933
3,100 Added 2.94%
108,500 $370,000
Q2 2020

Aug 07, 2020

BUY
$2.11 - $3.38 $68,153 - $109,174
32,300 Added 44.19%
105,400 $356,000
Q1 2020

May 06, 2020

SELL
$1.83 - $3.45 $50,325 - $94,875
-27,500 Reduced 27.34%
73,100 $170,000
Q4 2019

Feb 05, 2020

SELL
$3.5 - $10.35 $47,250 - $139,725
-13,500 Reduced 11.83%
100,600 $366,000
Q2 2019

Aug 09, 2019

BUY
$7.36 - $11.26 $93,472 - $143,002
12,700 Added 12.52%
114,100 $982,000
Q4 2018

Feb 08, 2019

SELL
$6.39 - $16.99 $56,232 - $149,512
-8,800 Reduced 7.99%
101,400 $887,000
Q2 2018

Aug 10, 2018

BUY
$14.31 - $21.75 $210,357 - $319,725
14,700 Added 15.39%
110,200 $2.31 Million
Q1 2018

May 10, 2018

BUY
$16.09 - $23.07 $43,443 - $62,289
2,700 Added 2.91%
95,500 $1.54 Million
Q4 2017

Feb 13, 2018

BUY
$13.36 - $20.73 $164,328 - $254,979
12,300 Added 15.28%
92,800 $1.76 Million
Q2 2017

Aug 11, 2017

BUY
N/A
80,500
80,500 $600,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.